However, our analysis did not find that leukocyte count ≥100,000 uL [14], eGFR < 60 mL/min/1.73 m2 [13], ALT ≥ 100 U/L [17], and poor cytogenetic risks [18] were attributed to early mortality in AML patients. This evidence concerns the gene GPT and acute myeloid leukemia.